Androgenetic Alopecia
📧 Sign up to get email alerts when something new happens for Androgenetic Alopecia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-06-07FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for finasteride filed by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2022-05-18FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Finasteride submitted by Aurobindo Pharma Limited.
-
FDA approval · 2022-05-05FDA Approved: FINASTERIDE — Supplemental Application (Dr Reddys Laboratories Inc)
FDA approved a supplemental application for finasteride from Dr Reddys Laboratories Inc., authorizing a generic Finasteride product.
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia [Phase 3]
A Phase 3 trial evaluating adipose-derived stem cell conditioned media as a new treatment approach for hair regrowth in male androgenetic al…
-
FDA approval · 2022-03-11FDA Approved: FINASTERIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for finasteride from Ascend Laboratories, LLC, granting approval of a generic finasteride product un…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-03-11FDA Approved: FINASTERIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Camber Pharmaceuticals to market a generic finasteride product, expanding access to the referenc…
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001 [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating pharmacokinetic/pharmacodynamic profiles and safety of IVL3001 in androgenetic alopecia has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111) [Phase 3]
Phase 3 trial update evaluating the effects of finasteride on serum prostate-specific antigen in androgenetic alopecia.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia [Phase 2, Phase 3]
A Phase 2/3 trial evaluating SM04554 topical solution for efficacy and safety in male androgenetic alopecia has been completed.
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: DUS on the Prescribing Indications for CPA/EE in 5 European Countries
Clinical trial update on prescribing indications for CPA/EE across five European countries; study completed with posted results.
-
FDA approval · 2021-08-25FDA Approved: PROSCAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for PROSCAR (finasteride) by Organon LLC, resulting in updates to the product's labeling under t…
-
CLINICAL_TRIALS research · 2021-08-02Clinical Trial Update: Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).
A completed clinical trial examining the association between androgenetic alopecia and the severity of COVID-19, with results posted in 2021…
-
FDA approval · 2021-06-15FDA Approved: PROSCAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for PROSCAR (finasteride) submitted by Organon LLC.
-
FDA approval · 2021-06-15FDA Approved: PROPECIA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for PROPECIA (finasteride) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers [Phase 2]
Phase 2a trial of FOL-005 topical formulations investigating hair growth potential and safety in healthy male volunteers for androgenetic al…
-
FDA approval · 2020-12-29FDA Approved: WOMENS ROGAINE UNSCENTED — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for Women's Rogaine Unscented (minoxidil) from Kenvue Brands LLC.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution [Phase 2]
Phase 2 trial update for ATI-50002 topical solution in androgenetic alopecia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: The Effect of Platelet Rich Plasma on Non-scarring Alopecia [NA]
Clinical trial assessing the effect of platelet-rich plasma on non-scarring alopecia, completed with results posted in 2020.
-
FDA approval · 2020-06-10FDA Approved: HAIR REGROWTH TREATMENT — Supplemental Application (CVS Pharmacy)
FDA approved a supplemental application for a hair regrowth treatment using minoxidil submitted by CVS Pharmacy.
-
FDA approval · 2020-05-19FDA Approved: MINOXIDIL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for MINOXIDIL (minoxidil) by Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5% [Phase 3]
Phase 3 trial evaluating a topical herbal solution for androgenetic alopecia and its comparison with Minoxidil 5%.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia [Phase 4]
A Phase 4 trial comparing topical cetirizine 1% with minoxidil 5% gel for androgenetic alopecia is ongoing or not yet updated in status.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing [Phase 2]
Phase 2 trial evaluating topically applied SM04554 for androgenetic alopecia completed.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) [Phase 2]
Phase 2 trial assessing safety, tolerability, and efficacy of topical SM04554 solution in men with androgenetic alopecia has completed.
-
FDA approval · 2020-01-31FDA Approved: WOMENS ROGAINE UNSCENTED — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Women's Rogaine Unscented (minoxidil) from Kenvue Brands LLC.